Ads
related to: fda
Search results
FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst
Reason.com via Yahoo News· 2 days agoMAPS Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock...
FDA rejects MDMA for PTSD treatment
Boing Boing· 17 hours agoAn FDA panel voted against allowing for MDMA to be used in treating PTSD earlier this week. Clearly, whoever was on the panel hadn't ever been to a three-day rave in the desert ...
FDA rescinds marketing ban on Juul vaping products - ABC17NEWS
ABC17 NEWS· 1 day agoJuul said Thursday its products will remain on the market during scientific review. In 2022, the FDA issued a marketing ban on Juul products, including devices and tobacco and menthol-flavored pods.
FDA warns parents about Crecelac infant formula—what parents need to know about the recall
Motherly via Yahoo News· 3 days agod3sign/Getty/FDA The FDA has issued an alert warning parents to avoid buying formula from a Texas...
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program - Moderna...
Benzinga· 1 day agoThursday, the FDA selected Moderna Inc’s MRNA mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program. “Selection for this ...
FDA rejects MDMA drug for PTSD
WDVM via Yahoo News· 2 days agoAn FDA panel has rejected a first-of-its kind proposal to use the psychedelic drug MDMA as a treatment for PTSD, which could have a major impact on those...
FDA panel picks JN.1 subvariant for fall COVID vaccines
The Hill via Yahoo News· 2 days agoThe expert advisory panel for the Food and Drug Administration (FDA) unanimously voted Wednesday in...
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
KSL Salt Lake City· 2 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
FDA rescinds 2022 Juul ban, company to pursue marketing authorization
Investing.com· 2 days agoFDA rescinds 2022 Juul ban, company to pursue marketing authorization
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 3 days agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...